Although to be fair the presentation also included revised earnings.
UPDATE ON PFIZER’S PHASE 1B OPEN-LABEL MINI-DYSTROPHIN GENE THERAPY TRIAL FOR DUCHENNE, page-33
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.61M | |||
| Open | High | Low | Value | Volume |
| 7.5¢ | 7.8¢ | 7.5¢ | $2.881K | 37.28K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 231 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 1 | 1 |
View Market Depth
| Last trade - 15.59pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.5¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.8¢ | 7.5¢ | 100937 | ||
| Last updated 15.33pm 13/05/2024 ? | |||||
| PER (ASX) Chart |